Michael Wilhelm
Founder, Chairman & Chief Operating Officer
Background & Experience
Michael Wilhelm is a seasoned leader in the biotech industry, with extensive expertise in pipeline development, investor relations, and strategic partnerships. He currently serves as President and CEO of New Amsterdam Sciences, Inc., where he has driven continuous growth and operational efficiencies, raising $50M in investments.
Previously, he served as Director of Strategic Partnering and Public Relations, growing corporate sponsorships and developing essential industry partnerships. Since 1996, he has been Founder, Managing Director, and Principal at Foresight Capital Corporation, overseeing private equity and debt funding exceeding $100M.
Earlier in his career, as CEO and Chairman of ImmuneRegen BioSciences Holdings, Inc., Wilhelm secured over $100M in initial capital, facilitating significant business strategies and relationships in the regenerative medicine sector.